These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis. Mori Y; Gonzalez Medina M; Liu Z; Guo J; Dingwell LS; Chiang S; Kahn CR; Husain M; Giacca A Diab Vasc Dis Res; 2021; 18(3):14791641211027324. PubMed ID: 34190643 [TBL] [Abstract][Full Text] [Related]
4. Generation and Comparative Analysis of an Warthi G; Faulkner JL; Doja J; Ghanam AR; Gao P; Yang AC; Slivano OJ; Barris CT; Kress TC; Zawieja SD; Griffin SH; Xie X; Ashworth A; Christie CK; Bryant WB; Kumar A; Davis MJ; Long X; Gan L; Belin de Chantemele EJ; Lyu Q; Miano JM Nat Cardiovasc Res; 2022 Nov; 1(11):1084-1100. PubMed ID: 36424917 [TBL] [Abstract][Full Text] [Related]
5. Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ. Rautureau Y; Paradis P; Schiffrin EL Methods Mol Biol; 2017; 1527():381-407. PubMed ID: 28116732 [TBL] [Abstract][Full Text] [Related]
8. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Regan CP; Manabe I; Owens GK Circ Res; 2000 Sep; 87(5):363-9. PubMed ID: 10969033 [TBL] [Abstract][Full Text] [Related]
9. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-independent recombination in the RIP-CreER mouse. Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464 [TBL] [Abstract][Full Text] [Related]
11. Oral and Injected Tamoxifen Alter Adult Hippocampal Neurogenesis in Female and Male Mice. Smith BM; Saulsbery AI; Sarchet P; Devasthali N; Einstein D; Kirby ED eNeuro; 2022; 9(2):. PubMed ID: 35387845 [TBL] [Abstract][Full Text] [Related]
12. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity. Undeutsch H; Löf C; Offermanns S; Kero J Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757 [TBL] [Abstract][Full Text] [Related]
13. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810 [TBL] [Abstract][Full Text] [Related]